Huberman Lab Clips | How Ketamine Works & Its Potential for Depression Relief | Dr. Andrew Huberman @HubermanLabClips | Uploaded October 2024 | Updated October 2024, 1 day ago.
Dr. Andrew Huberman discusses how the antidepressant effects of ketamine are influenced by its interaction with the opioid system, highlighting a Stanford study that shows blocking opioid receptors with naltrexone diminishes ketamine's antidepressant efficacy.

Dr. Andrew Huberman is a tenured professor of neurobiology and ophthalmology at Stanford University School of Medicine and host of the Huberman Lab podcast.

Watch the full episode on YouTube: youtu.be/Rxmv7rT9leo
Show notes: hubermanlab.com/episode/ketamine-benefits-and-risks-for-depression-ptsd-and-neuroplasticity
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism (The American Journal of Psychiatry): bit.ly/48dEAqT

Social & Website
Instagram: instagram.com/hubermanlab
Threads: threads.net/@hubermanlab
X: https://x.com/hubermanlab
Facebook: facebook.com/hubermanlab
TikTok: tiktok.com/@hubermanlab
LinkedIn: linkedin.com/in/andrew-huberman
Website: hubermanlab.com
Newsletter: hubermanlab.com/newsletter

Timestamps
00:00 Introduction to the Opioid Crisis
00:32 Understanding Opioid Receptors
00:59 Ketamine & Its Effects
01:32 Clinical Studies on Ketamine
02:54 The Role of Hydroxynorketamine
03:52 Opioid System's Impact on Depression Relief
04:31 Key Study on Ketamine & Naltrexone
06:22 Implications for Psychiatric Treatment
07:32 Concluding Thoughts on Drug Effects

#HubermanLab #Science

Disclaimer & Disclosures: hubermanlab.com/disclaimer